FindTrial
Sign In

To find out if subclinical atherosclerosis is more common in patients of psoriasis without metabolic syndrome compared to those patients of psoriasis not having metabolic syndrome

Assessment of subclinical atherosclerosis in patients of psoriasis with and without metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/035003
Enrollment
30
Registered
2021-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

DR D Y Patil Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients with active psoriasis more than 18 years of age 2)Patients willing to undergo investigations 3)Patients willing to give consent

Exclusion criteria

Exclusion criteria: 1)Patient not consenting to participate 2)Patient who are known case of cardiovascular disease

Design outcomes

Primary

MeasureTime frame
Assessment of subclinical atherosclerosis in patients of psoriasis with and without metabolic syndrome.Timepoint: Baseline—

Secondary

MeasureTime frame
1. To assess prevalence of cardiovascular risk factor and metabolic syndrome using clinical and laboratory investigations 2. To assess subclinical atherosclerosis by Carotid Intima-Media thickness (CIMT) and Epicardial Fat Thickness (EFF) using B-mode ultrasound and 2D ECHO respectively. 3. To correlate cardiovascular risk factors with the duration and severity of psoriasis. 4. To assess prevalence of subclinical atherosclerosis in the patients with no known risk factors.Timepoint: Baseline—

Countries

India

Contacts

Public ContactShreya Deoghare

Dr. D. Y. Patil Medical College & Hospital Pimpri

hemant.vasant16@gmail.com9422087726

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026